Thank you and see you next year!

en English


Paramjeet Kaur, PhD

Reviewer, Division of Bioequivalence II, OB, OGD, CDER

Dr. Paramjeet Kaur is a Reviewer in the Division of Bioequivalence II, Office of Generic Drugs, CDER, FDA.  She is responsible for the review of bioequivalence studies submitted in support of approval of generic drug applications and responding to controlled correspondences.

Dr. Kaur received her Bachelor in Pharmacy from the Banaras Hindu University, India, and Doctorate in Industrial Pharmacy from St. John’s University, USA.

Skip to content